Clinical Trial: Efficacy Of Supplemental L-Arginine in Preventing Preeclampsia in Pregnant Women

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07912866) titled 'Efficacy Of Supplemental L-Arginine in Preventing Preeclampsia in Pregnant Women' on Oct. 28.

Brief Summary: This study was designed to assess whether daily L-arginine supplementation could prevent preeclampsia in pregnant women at increased risk. Preeclampsia, a pregnancy complication involving high blood pressure and possible organ damage, was the condition of interest. The study hypothesis was that L-arginine supplementation would be more effective than placebo in preventing preeclampsia before delivery.

The study was designed as a randomized controlled trial at the Department of Gynaecology and Obstetrics, Bahawal Victoria Hospi...